Trial intelligence / Profile preview

Remimazolam vs propofol for hemodynamics during fiberoptic bronchoscopy after cardiovascular surgery

ChiCTR2200056799Phase 4Not yet recruiting

Sponsor
The First Affiliated Hospital of Guangxi Medical University
Start
Feb 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of remimazolam in cardiac surgery (2 arms), sponsored by The First Affiliated Hospital of Guangxi Medical University. Primary endpoints: Heart rate, Mean arterial pressure and 2 more. Planned start Feb 2022; status: not yet recruiting.

02

Drugs

remimazolam
03

Conditions

cardiac surgery

Beyond the preview

Go deeper on ChiCTR2200056799.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2200056799.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call